openPR Logo
Press release

Rising Prevalence Of Congenital Disorders Driving Growth In The Market: A Key Driver Powering Arthrogryposis Market Growth In 2025

06-17-2025 07:32 AM CET | Health & Medicine

Press release from: The Business Research Company

Arthrogryposis

Arthrogryposis

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Arthrogryposis Market Size and Its Estimated Growth Rate?
In recent times, the market size for arthrogryposis has experienced solid growth. It is projected to rise from $0.93 billion in 2024 to nearly $0.98 billion in 2025, marking a compound annual growth rate (CAGR) of 5.8%. The growth during the historical period is primarily due to an increasing number of osteoarthritis cases, a rise in sports-related injuries, an aging population, an increase in sedentary behaviors, and heightened awareness about therapeutic options for osteoarthritis.

Strong expansion is forecasted for the arthrogryposis market size in the upcoming years, with expected growth reaching $1.22 billion in 2029, reflecting a compound annual growth rate (CAGR) of 5.5%. This increase during the forecast period is likely due to the increasing geriatric population, heightened usage of pain medications, a growing number of sports-related injuries, a rising incidence of osteoarthritis, and a larger population at risk of developing osteoarthritis. Crucial trends anticipated during this period comprise advances in medical technology, breakthroughs in genetic research, technological progression in treatment options, the creation of non-surgical treatments, and advancements in biologics and stem cell therapies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21105

How Are Emerging Segments Shaping the Arthrogryposis Market Landscape?
The arthrogryposis market covered in this report is segmented -

1) By Type: Classic Arthrogryposis, Distal Arthrogryposis, Amyoplasia
2) By Treatment Type: Occupational Therapists, Physical Therapy, Surgery, Imaging Diagnostics, CT Scan
3) By Patient Age: Children, Adults, Elderly
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Classic Arthrogryposis: Multiple Joint Involvement, Flexion Contractures, Severe Muscle Weakness, Progressive Arthrogryposis, Intellectual Impairment
2) By Distal Arthrogryposis: Isolated Limb Involvement, Contractures of Hands and Feet, Distal Joint Contractures, Autosomal Dominant Inheritance
3) By Amyoplasia: Severe Limb Contractures, Muscle Hypotonia (low muscle tone), No Cognitive Impairment, Symmetric Joint Involvement, Lack Of Muscle Development In Affected Limbs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21105&type=smp

Which Growth Factors Are Influencing Arthrogryposis Market Expansion?
The surge in the number of congenital disorders is anticipated to stimulate the arthrogryposis market's expansion moving forward. Congenital disorders are conditions that are present at birth due to abnormal development in the womb. The increasing frequency of these disorders is linked to progress in prenatal diagnostic methods, environmental factors, genetic alterations, and lifestyle transformations. Arthrogryposis aids in understanding these disorders, focusing on the importance of fetal movement, genetic elements, and neuromuscular development in musculoskeletal anomalies. For example, the World Health Organization, a Switzerland-based intergovernmental organization, reported in February 2023 that about 240,000 infants worldwide die from congenital disorders within their first 28 days each year. Additionally, these disorders are estimated to be the cause of approximately 170,000 deaths in children between the ages of 1 month and 5 years. Therefore, the increased prevalence of congenital disorders is fueling the arthrogryposis market's growth. The expansion of telehealth services is also anticipated to boost the arthrogryposis market's growth. Telehealth services, which involve the use of digital communication channels such as video chats, phone calls, and online messaging for distant health care consultations and services, have made medical care more accessible to patients in their homes or other locations. The adoption of telehealth services has increased as they offer convenience, accessibility, and a potential reduction in healthcare expenses, while improving patient access to care in remote or underserved regions. In the context of arthrogryposis, telehealth services facilitate remote assessments, early detection, and long-term management of joint contractures, thus improving access to specialized care for mobility-challenged patients. For instance, the Australian Digital Health Agency reported in May 2024 that over 95,000 healthcare providers had offered telehealth services to 18 million patients, amounting to 118.2 million telehealth services over the previous two years. Therefore, the expansion of telehealth services is contributing to the growth of the arthrogryposis market.

Who Are the Dominant Players Across Different Arthrogryposis Market Segments?
Major companies operating in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children's Hospital, Boston Children's Hospital, Phoenix Children's Hospital Inc., Children's Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children's Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children's Hospital, Arthrogryposis Multiplex Congenita Support Inc.

What Are the Major Trends Shaping the Arthrogryposis Market?
Leading businesses in the arthrogryposis market are concentrating on the development of innovative surgical procedures such as carpal wedge osteotomy. This method helps to improve the movability of joints, decrease contractures and provide a better quality of life to patients. Carpal wedge osteotomy involves the removal of a piece of wrist bone shaped like a wedge, which helps to rectify joint abnormalities and improve the functionality of the hand in patients diagnosed with arthrogryposis. For example, Akron Children's Hospital, an American children's acute care hospital, introduced a combination of carpal wedge osteotomy and flexor-pronator slide in November 2022, which is designed to boost joint flexibility in individuals afflicted with this rare disorder characterized by rigid or contracted joints.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/arthrogryposis-global-market-report

Which Geographic Regions Are Expected to Dominate the Arthrogryposis Market in the Coming Years?
North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arthrogryposis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Arthrogryposis Market?
2. What is the CAGR expected in the Arthrogryposis Market?
3. What Are the Key Innovations Transforming the Arthrogryposis Industry?
4. Which Region Is Leading the Arthrogryposis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Congenital Disorders Driving Growth In The Market: A Key Driver Powering Arthrogryposis Market Growth In 2025 here

News-ID: 4069442 • Views:

More Releases from The Business Research Company

Top Market Shifts Transforming the Quantum-Enhanced Predictive Genomics Market Landscape: Key Insights
Top Market Shifts Transforming the Quantum-Enhanced Predictive Genomics Market L …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Quantum-Enhanced Predictive Genomics Market Through 2025? The market size for quantum-enhanced predictive genomics has experienced rapid expansion in the past few years. The market is projected to increase from $1.45 billion in 2024 to $1.95 billion in 2025, displaying a compound annual
Increasing Demand For Minimally Invasive Aesthetic Procedures Fueling The Growth Of The Market Due To Shorter Recovery Times And Reducing Risks: Powering Innovation and Expansion in the Global Poly-L-Lactic Acid (PLA) Thread Lift Market by 2025
Increasing Demand For Minimally Invasive Aesthetic Procedures Fueling The Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Poly-L-Lactic Acid (PLA) Thread Lift Market Through 2025? In recent times, the market size of the poly-L-lactic acid (PLA) thread lift has expanded exponentially. This market is projected to increase from $1.28 billion in 2024 to $1.49 billion in 2025, with a
2025-2034 Pharmerging Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Pharmerging Market Evolution: Disruptions, Innovations, and Untapped O …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Pharmerging Market Through 2025? The size of the pharmerging market has expanded significantly over the past few years. Its projected growth is slated to rise from $2042.23 billion in 2024 to $2259.20 billion in 2025, with a compound annual growth rate (CAGR)
Soaring Demand Set to Propel Personalized Gene Therapy Treatment Market to $17.65 Billion by 2029
Soaring Demand Set to Propel Personalized Gene Therapy Treatment Market to $17.6 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Personalized Gene Therapy Treatment Market Through 2025? In recent times, there has been substantial growth in the market size of personalized gene therapy treatment. Predictions suggest that the market will expand from a worth of $6.93 billion in 2024 to $8.38 billion

All 5 Releases


More Releases for Arthrogryposis

Arthrogryposis Management Market to Reach USD 900.3 million by 2035 with Advance …
The global Arthrogryposis Management Market is poised for substantial growth, with market value expected to rise from USD 502.7 million in 2025 to USD 900.3 million by 2035, registering a compound annual growth rate (CAGR) of 6.0%. The increasing prevalence of arthrogryposis multiplex congenita (AMC), rising awareness among healthcare providers, and adoption of multidisciplinary treatment approaches are driving this expansion. Arthrogryposis, a rare congenital disorder characterized by joint contractures, affects approximately
Non-Small Cell Lung Carcinoma Market to Reach USD 25.9 Billion by 2035, Growing …
The global Non-Small Cell Lung Carcinoma (NSCLC) market, currently valued at USD 10.0 billion in 2025, is projected to expand significantly, reaching USD 25.9 billion by 2035. According to the latest industry analysis, the market is set to grow at a compound annual growth rate (CAGR) of 10.0%, propelled by advances in precision medicine, rising incidence of lung cancer, and continuous innovations in immuno-oncology. Market Growth Dynamics The NSCLC market is undergoing
Kinase Inhibitor in Autoimmune Diseases Market to Reach USD 89.2 Billion by 2035 …
New York, September 4, 2025 - The global Kinase Inhibitor in Autoimmune Diseases Market is set for strong expansion, projected to grow from USD 52.7 billion in 2025 to USD 89.2 billion by 2035, at a CAGR of 5.4%, according to recent industry analysis. This growth underscores the increasing adoption of targeted therapies, shifting treatment paradigms, and growing investments in autoimmune disease research and drug development. Market Growth Factors and Industry
Arthrogryposis Treatment Market Size Report 2032: Major Companies, Emerging Drug …
DelveInsight's "Arthrogryposis Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Arthrogryposis, historical and forecasted epidemiology as well as the Arthrogryposis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover which therapies are expected to grab the Arthrogryposis Market Share @ Arthrogryposis Market Outlook- https://www.delveinsight.com/sample-request/arthrogryposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Arthrogryposis Market Report • In July 2025, AbbVie announced a
Arthrogryposis Market Analysis Research Report [2025-2034]
The Arthrogryposis Market Is Set To Grow At An Estimated CAGR Of 7.4% From 2025 To 2034, Rising From $1.2 Billion In 2024 To $2.4 Billion By 2034. On April 29, 2025, Exactitude Consultancy., Ltd. released a research report titled "Arthrogryposis Market" This report offers a new perspective on the Arthrogryposis Market covering an extensive range of aspects including market overview, expenditure analysis, import trends, segmentation, key players, and opportunities spanning.
Arthrogryposis Market Set to Reach $1.22 Billion by 2029 with 5.5% Yearly Growth
What industry-specific factors are fueling the growth of the arthrogryposis market? The increasing prevalence of congenital disorders is expected to fuel the growth of the arthrogryposis market moving forward. Congenital disorders refer to structural or functional abnormalities present at birth that occur during fetal development. The growing incidence of congenital disorders is attributed to factors such as improvements in prenatal diagnostics, environmental exposures, genetic mutations, and changes in lifestyle. Arthrogryposis helps